VAERS Explorer
Back to explore

Report #2887380

Received Mar 2, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURERUNKUNK

Symptoms (1)

Guillain-Barre syndrome

Symptom narrative

My brother-in-law got Guillain Barre syndrome from the vaccine which is way worse than shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: My brother-in-law got Guillain Barre syndrome from the vaccine which is way worse than shingles) (serious criteria GSK medically significant). The outcome of the guillain barre syndrome was not reported. The reporter considered the guillain barre syndrome to be related to Shingles vaccine. The company considered the guillain barre syndrome to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 23-FEB-2026 This case was reported by a reporter via interactive digital media. The reporter mentioned that TV ad even said it could cause that The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Guillain-Barre syndrome, on an unknown time after vaccination with unknown dose of Shingles vaccine, in a male patient. Based on the available information a possible causality that the event was caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received.